Display Settings:

Format

Send to:

Choose Destination
    Am J Psychiatry. 2000 Dec;157(12):2052-4.

    Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.

    Source

    Department of Psychiatry, University of Pennsylvannia School of Medicine, Philadelphia, 19104, USA. kampman_k@mail.trc.upenn.edu

    Abstract

    OBJECTIVE:

    The study examined the effectiveness of amantadine in reducing cocaine withdrawal symptoms and improving treatment outcome among cocaine-dependent patients in outpatient treatment.

    METHOD:

    Sixty-one cocaine-dependent subjects participated in a double-blind, placebo-controlled trial of amantadine.

    RESULTS:

    Among subjects with severe cocaine withdrawal symptoms at the start of treatment, those who received amantadine used significantly less cocaine during the trial than did subjects who received placebo. Compared to subjects who received placebo, subjects who received amantadine submitted significantly more benzoylecgonine-negative urine samples and used cocaine on significantly fewer days during the trial.

    CONCLUSIONS:

    Amantadine may be an effective treatment for cocaine-dependent patients with severe cocaine withdrawal symptoms.

    PMID:
    11097979
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Silverchair Information Systems

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk